SCHEMBL11961574

SCHEMBL11961574

Cc1ccc(N2CCNC3(CC3)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.55
CHRNB2 P17787 3/20 0.47
CHRNA4 P43681 3/20 0.47
CHRNB4 P30926 2/20 0.47
CHRNA3 P32297 2/20 0.47
CHRNA1 P02708 1/20 0.41
CHRNG P07510 1/20 0.41
CHRNB1 P11230 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRND Q07001 1/20 0.41
SOS1 Q07889 1/20 0.38
MAPT P10636 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRL1 P41146 1/20 0.35
WEE1 P30291 1/20 0.35
PLK1 P53350 1/20 0.35
HTR3A P46098 3/20 0.35
HTR3E A5X5Y0 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12363106 0.85 CHRNB2 (0.58) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL12363107 0.84 CHRNB2 (0.53) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL24319859 0.84 ADRB1 (0.50) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL31713251 0.83 CHRNB2 (0.47) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL16853414 0.83 CHRNB2 (0.47) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL29310098 0.82 CHRNB2 (0.47) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL29310678 0.82 CHRNB2 (0.43) ADRB1CHRNB2CHRNA4CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL16540236 0.81 CHRNB2 (0.46) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1
SCHEMBL82562 0.81 ADRB1 (0.56) ADRB1MAPTMEN1KMT2AHTR3A
SCHEMBL30047809 0.79 CHRNB2 (0.55) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155201-B1 QUINOXALINE DERIVATIVES AS INHIBITORS OF THE TYROSINE KINASE ACTIVITY OF JANUS KINASES NOVARTIS AG (CH) 2012-08-01 EP disclosed